25+ Presentations from Top Pharma at Bioprocessing Summit Europe 2026
Model-Based Evaluation of Product and Solvent Recycling Technologies in Downstream Processing
Oskar Bergmann, Industrial PhD Student, Novo Nordisk
Mechanism-Driven Momentum: Unlocking Speed, Robustness, and Insight in Early Development of Complex Molecules
Greta Csalane Besenyei, PhD, Scientist, Downstream Processing, Astrazeneca
USP Development and in silico Modelling
Ayca Cetinkaya, PhD, Senior Scientist, AstraZeneca
Latest Industry Trends and Challenges in Downstream Processing
Pierre Djillali, Engineer, Downstream Processing, Sanofi
AAV Analytics to Monitor Efficacy and Quality
Christoph Gstöttner, PhD, Scientist, Roche
Ultra-Fast Analysis of Product Quality Attributes by Cyclic Ion Mobility Mass Spectrometry
Camile Jenny, Researcher, Analytical Characterization, Novartis
Development and Optimisation of an Intensified Process for a High-Value Commercial Process Using Advanced at-Line Metabolic Data
Emanuel Kreidl, PhD, Senior Expert, Science & Technology, Technical Research & Development, Novartis Pharmaceutical Manufacturing GmbH
A Semi-Automated Workflow for Screening Injectable Liquid Fixed-Dose Combination (FDC) Formulations of Large Synthetic Molecules
Dan Lundberg, PhD, Associate Principal Scientist, Pharmaceutical Sciences - Advanced Drug Delivery, AstraZeneca
A Case Study on Analytical Challenges with Engineered AAVs: Why Evaluation Methods Matter
Chelsey Mattison, Senior Scientist, Novartis
CHO Engineering to Avoid Toxic Byproduct Production
Bhanu Chandra Mulukutla, PhD, Senior Principal Scientist, Group Leader, Process Development, Pfizer Inc.
Overcoming the Challenges of Biophysical Characterisation of IgG2
Emmanuel Nony, PhD, Director, R&D, Servier
Proof of Concepts of Disruptive Process Intensification Solutions
Margaux Ouvry, Process Engineer, Downstream Processing & Mfg Science & Technology, Sanofi Grp
Speed2Clinic: Continuously-Learning AI Model for Efficient and Accelerated Cell-Line Development for Monoclonal-Antibody Production
Stella Papadaki, Data Scientist, Functional Characterization, Roche
Addressing Downstream Bottlenecks in High-Titre Bioprocessing: Innovative Solutions for Enhanced Throughput
Andreja Pirnat, Expert, Science and Technology, Novartis Pharma
Bringing Gene Therapy Productivity to the Next Level
Nic Preyat, PhD, Associate Director, Gene Therapy CMC Development, UCB Pharma
Are We There Yet? A Digital Maturity Model for Enabling Process Monitoring and Artificial Intelligence in Biologics Manufacturing
Jack Prior, PhD, Head, Process Monitoring & Data Science & AI Strategy, Sanofi Group
Control Strategies and Analytical Method Development for Legacy and Emerging Starting Materials in Oligonucleotide Manufacturing
Dennis Rhodes, Associate Director, Ionis Pharmaceuticals Inc.
Development of a Novel Automated Workflow for Quantifying Glycogen in Tissue Lysate with Enhanced Sensitivity
Avraham Rosenberg, MS, Senior Scientist, Analytical Chemistry, Regeneron
Optimising an Immunoprecipitation Mass-Spectrometry Workflow for Enrichment of Surface Proteins: Applications to Surrogate CAR T Cells.
Nicolle Serrano SantoDomingo, Senior Scientist, Novartis
Maximising Productivity of Protein A Capture
Isabelle Savoy, Senior Manager, Science and Technology, Novartis Pharma
Can Viruses Flee from Ice Crystals? Understanding Freeze/Thaw Effects in Virus-Drug Substance (Large-Scale) Handling
Matthias Schad, Senior Scientist, Advanced Therapy Medicinal Products, Boehringer Ingelheim Pharma GmbH & Co. KG
Structural insights into Antibody-Antibody Interactions in Sandwich ELISA: Implications for Assay Development and Performance
Yue Su, PhD, Scientist, Regeneron
Greener Bioprocessing: A Data-Driven Lifecycle Approach to Sustainable Antibody Production
Thomas Troebs, Pharmaceutical Biotech Production & Development, F Hoffmann La Roche AG
Downstream Processing: Current Challenges, Recent Advances and Future Perspectives
Fabian Vogt, PhD, Lab Head, Downstream Development, Boehringer Ingelheim Pharma GmbH & Co KG
Ready or Not: Transforming Developability Assessment for What’s Next
Paul Wassmann, PhD, Senior Principal Scientist, Biologics Research Center, Novartis
Automated Screening of Post-Translational Modifications Using LC-MSE and Customised Data Processing Tools
Joy Yoon, Scientist, Regeneron Pharmaceuticals
Optimising a Flowthrough Multimodal Chromatography
Wendi Zhang, PhD, Senior Scientist, Downstream Processing, AbbVie Inc.